REGENXBIO Inc. Annual Costs and Expenses in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
REGENXBIO Inc. quarterly/annual Costs and Expenses history and growth rate from 2013 to 2023.
  • REGENXBIO Inc. Costs and Expenses for the quarter ending June 30, 2024 was $78.3M, a 15.8% decline year-over-year.
  • REGENXBIO Inc. Costs and Expenses for the twelve months ending June 30, 2024 was $338M, a 7.46% decline year-over-year.
  • REGENXBIO Inc. annual Costs and Expenses for 2023 was $358M, a 4.59% decline from 2022.
  • REGENXBIO Inc. annual Costs and Expenses for 2022 was $376M, a 21% increase from 2021.
  • REGENXBIO Inc. annual Costs and Expenses for 2021 was $310M, a 13.4% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $358M -$17.2M -4.59% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 $376M +$65.2M +21% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 $310M +$36.6M +13.4% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 $274M +$89.6M +48.6% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $184M +$53.8M +41.3% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $130M +$44.1M +51.1% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 $86.3M +$16.3M +23.4% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-26
2016 $69.9M +$39.2M +128% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2015 $30.7M +$20.9M +213% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-06
2014 $9.8M -$1.06M -9.77% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-07
2013 $10.9M Jan 1, 2013 Dec 31, 2013 10-K 2016-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.